The Role of the Breast Cancer Resistance Protein (ABCG2) in the Distribution of Sorafenib to the BrainSagar Agarwal, William F. Elmquist|Journal of Pharmacology and Experimental Therapeutics|2010Cited by 159
Localized Metabolomic Gradients in Patient-Derived Xenograft Models of GlioblastomaElizabeth C. Randall, Nathalie Y.R. Agar, Begoña Giménez et al.|Cancer Research|2019Cited by 99
Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastomaBianca M. Marin, Jann N. Sarkaria, Kendra A. Porath et al.|Neuro-Oncology|2021Cited by 81
Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastomaElizabeth C. Randall, Nathalie Y.R. Agar, Kristina B. Emdal et al.|Nature Communications|2018Cited by 79
Brain Distribution of a Panel of Epidermal Growth Factor Receptor Inhibitors Using Cassette Dosing in Wild-Type and Abcb1/Abcg2-Deficient MiceMinjee Kim, William F. Elmquist, Janice K. Laramy et al.|Drug Metabolism and Disposition|2019Cited by 49